FormFactor, Inc. filings document a Nasdaq-listed semiconductor test and measurement company with common stock registered under the symbol FORM. Its Form 8-K reports furnish quarterly operating results and financial-condition updates, while other material-event filings cover restructuring actions tied to manufacturing consolidation, executive and director changes, and a revolving credit agreement for working capital and general corporate purposes.
The company’s proxy materials describe board elections, committee matters, executive compensation, equity awards, pay-versus-performance disclosure and other annual meeting governance subjects. Together, the filings provide formal disclosure on FormFactor’s capital structure, governance practices, operating performance and risk-related corporate actions.
An affiliate of the issuer has filed a notice of proposed sale under Rule 144 to sell 2,770 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ market. The planned sale has an aggregate market value of $265,421.68, with the issuer reporting 77,517,097 shares outstanding.
The shares to be sold were all acquired as restricted stock from the issuer on May 19, 2024, in multiple grants that together total 2,770 shares, with payment described as not applicable. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
An insider has filed a notice of proposed sale of 5,500 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $500,225.00 and are listed on NASDAQ.
The filing states that 77,517,097 shares of the issuer’s common stock are outstanding. The 5,500 shares to be sold were acquired on 05/19/2024 as restricted stock from the issuer, with payment noted as “Not Applicable.”
An insider of FORM has filed a Rule 144 notice to sell 2,000 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC, has an aggregate market value of $177,680 and is expected around February 9, 2026 on the NASDAQ.
The 2,000 shares were acquired as restricted stock from the issuer on May 14, 2022. Shares outstanding were 77,517,097 at the time stated, which serves as a baseline figure relative to this planned sale.
FormFactor, Inc. filed a current report to note that it released its financial results for the fourth quarter of fiscal 2025, which ended on December 27, 2025. The company issued these results in a press release dated February 4, 2026.
The press release is provided as Exhibit 99.01 to the report and is furnished rather than filed, meaning it is not automatically subject to certain liability provisions under U.S. securities laws or incorporated into other SEC filings unless specifically referenced.
FormFactor, Inc. insider filing reports planned stock sales by CEO Mike Slessor. On January 15, 2026, Slessor, who is both CEO and a director, sold 6,976 shares of FormFactor common stock at a weighted average price of $76.43 and an additional 6,112 shares at a weighted average price of $77.24.
The filing states these transactions occurred automatically under a Rule 10b5-1 trading plan adopted on August 19, 2025, which is designed to pre-arrange sales according to preset terms. After these sales, Slessor directly beneficially owned 472,907 shares of FormFactor common stock, as reported in the form.
Mike Slessor has filed a Form 144 notice to sell 13,088 shares of common stock through Morgan Stanley Smith Barney on the NASDAQ exchange, with an approximate sale date of January 15, 2026 and an aggregate market value of $1,005,295.82.
The shares to be sold are the same 13,088 common shares that were acquired as restricted stock from the issuer on June 4, 2022, with no separate cash payment noted at that time.
Over the prior three months, Slessor has already sold additional common shares of the same issuer, including 7,669 shares on December 17, 2025 for gross proceeds of $432,236.34, 8,403 shares on November 19, 2025 for $420,670.99, and 39,606 shares on January 6, 2026 for $2,574,390.00.
FormFactor, Inc. has approved restructuring plans to better align its cost structure and manufacturing footprint with current and expected demand and its strategic priorities. The company will consolidate its manufacturing facilities in Carlsbad and Baldwin Park, California, and expects personnel-related actions affecting approximately 200 to 300 employees, with most actions completed by the end of December 2026.
FormFactor expects to record total restructuring charges of about $30 to $40 million on a GAAP basis. This includes an estimated $20 to $25 million for impairment of leasehold improvements, facility exits and other costs, $9 to $13 million in severance, retention and other employee-related expenses, and $1 to $2 million for contract and lease terminations. Of the total, around $10 to $15 million are expected to be future cash expenditures, while approximately $20 to $25 million are expected to be non-cash charges, with most charges incurred in the current fiscal year.
FORM has a Form 144 notice indicating a planned sale of 39,606 common shares, with an aggregate market value of $2,574,390.00. The shares are to be sold through Morgan Stanley Smith Barney LLC on or around 01/06/2026, and the issuer reports 77,517,097 shares outstanding.
The seller acquired the 39,606 shares as performance shares from the issuer on 07/23/2024, with no separate cash payment. Over the prior three months, Mike Slessor sold additional common shares, including 7,669 shares on 12/17/2025 for $432,236.34 and 8,403 shares on 11/19/2025 for $420,670.99, all listed on the NASDAQ.
FormFactor Inc. CEO and director Mike Slessor reported automatic stock sales under a pre-arranged Rule 10b5-1 trading plan. On December 17, 2025, he sold 5,606 shares of common stock at a weighted average price of $56.19 and an additional 2,063 shares at a weighted average price of $56.82.
These transactions, totaling 7,669 shares, were executed pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. After these sales, Slessor beneficially owned 525,601 shares of FormFactor common stock directly.
FormFactor, Inc.